L. Roy Papp & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.33M | Sell |
6,448
-9
| -0.1% | -$3.08K | 0.25% | 63 |
|
|
2026
Q1 | $2.27M | Hold |
6,457
| – | – | 0.26% | 63 |
|
|
2025
Q4 | $2.11M | Hold |
6,457
| – | – | 0.23% | 67 |
|
|
2025
Q3 | $1.82M | Sell |
6,457
-1
| -0% | -$290 | 0.2% | 70 |
|
|
2025
Q2 | $1.8M | Hold |
6,458
| – | – | 0.21% | 73 |
|
|
2025
Q1 | $2.01M | Hold |
6,458
| – | – | 0.25% | 65 |
|
|
2024
Q4 | $1.68M | Hold |
6,458
| – | – | 0.2% | 76 |
|
|
2024
Q3 | $2.08M | Hold |
6,458
| – | – | 0.25% | 66 |
|
|
2024
Q2 | $2.02M | Buy |
6,458
+1
| +0% | +$294 | 0.24% | 69 |
|
|
2024
Q1 | $1.84M | Buy |
6,457
+241
| +4% | +$70.5K | 0.22% | 75 |
|
|
2023
Q4 | $1.79M | Hold |
6,216
| – | – | 0.22% | 72 |
|
|
2023
Q3 | $1.67M | Sell |
6,216
-655
| -10% | -$163K | 0.23% | 71 |
|
|
2023
Q2 | $1.53M | Hold |
6,871
| – | – | 0.2% | 79 |
|
|
2023
Q1 | $1.66M | Hold |
6,871
| – | – | 0.22% | 76 |
|
|
2022
Q4 | $1.8M | Sell |
6,871
-826
| -11% | -$221K | 0.25% | 73 |
|
|
2022
Q3 | $1.74M | Sell |
7,697
-60
| -0.8% | -$14.5K | 0.26% | 74 |
|
|
2022
Q2 | $1.89M | Buy |
7,757
+59
| +0.8% | +$14.5K | 0.27% | 70 |
|
|
2022
Q1 | $1.86M | Sell |
7,698
-640
| -8% | -$147K | 0.23% | 76 |
|
|
2021
Q4 | $1.88M | Sell |
8,338
-940
| -10% | -$198K | 0.21% | 79 |
|
|
2021
Q3 | $1.97M | Sell |
9,278
-700
| -7% | -$161K | 0.25% | 71 |
|
|
2021
Q2 | $2.43M | Buy |
9,978
+992
| +11% | +$244K | 0.31% | 63 |
|
|
2021
Q1 | $2.24M | Sell |
8,986
-2,008
| -18% | -$479K | 0.32% | 67 |
|
|
2020
Q4 | $2.53M | Sell |
10,994
-1,221
| -10% | -$282K | 0.29% | 63 |
|
|
2020
Q3 | $3.1M | Buy |
12,215
+100
| +0.8% | +$24.8K | 0.4% | 58 |
|
|
2020
Q2 | $2.86M | Sell |
12,115
-68
| -0.6% | -$15.5K | 0.4% | 56 |
|
|
2020
Q1 | $2.47M | Sell |
12,183
-213
| -2% | -$46.5K | 0.45% | 53 |
|
|
2019
Q4 | $2.99M | Buy |
12,396
+13
| +0.1% | +$2.87K | 0.43% | 54 |
|
|
2019
Q3 | $2.4M | Sell |
12,383
-157
| -1% | -$30.1K | 0.38% | 61 |
|
|
2019
Q2 | $2.31M | Buy |
12,540
+530
| +4% | +$94.9K | 0.36% | 62 |
|
|
2019
Q1 | $2.28M | Sell |
12,010
-556
| -4% | -$106K | 0.41% | 55 |
|
|
2018
Q4 | $2.45M | Buy |
12,566
+447
| +4% | +$87.2K | 0.51% | 45 |
|
|
2018
Q3 | $2.51M | Sell |
12,119
-100
| -0.8% | -$19.7K | 0.45% | 47 |
|
|
2018
Q2 | $2.26M | Sell |
12,219
-1,255
| -9% | -$222K | 0.43% | 54 |
|
|
2018
Q1 | $2.3M | Buy |
13,474
+4,274
| +46% | +$785K | 0.44% | 54 |
|
|
2017
Q4 | $1.6M | Buy |
9,200
+420
| +5% | +$74.3K | 0.32% | 62 |
|
|
2017
Q3 | $1.64M | Sell |
8,780
-498
| -5% | -$88.2K | 0.35% | 58 |
|
|
2017
Q2 | $1.6M | Hold |
9,278
| – | – | 0.35% | 62 |
|
|
2017
Q1 | $1.52M | Sell |
9,278
-151
| -2% | -$25.1K | 0.35% | 61 |
|
|
2016
Q4 | $1.38M | Sell |
9,429
-250
| -3% | -$37.6K | 0.32% | 67 |
|
|
2016
Q3 | $1.61M | Buy |
9,679
+1,159
| +14% | +$196K | 0.37% | 61 |
|
|
2016
Q2 | $1.3M | Sell |
8,520
-76
| -0.9% | -$11.8K | 0.31% | 69 |
|
|
2016
Q1 | $1.29M | Hold |
8,596
| – | – | 0.31% | 68 |
|
|
2015
Q4 | $1.4M | Sell |
8,596
-310
| -3% | -$48.7K | 0.34% | 63 |
|
|
2015
Q3 | $1.23M | Sell |
8,906
-1,256
| -12% | -$198K | 0.3% | 64 |
|
|
2015
Q2 | $1.56M | Buy |
10,162
+2,948
| +41% | +$472K | 0.35% | 62 |
|
|
2015
Q1 | $1.15M | Buy |
7,214
+379
| +6% | +$59.7K | 0.25% | 77 |
|
|
2014
Q4 | $1.09M | Sell |
6,835
-1,025
| -13% | -$160K | 0.24% | 79 |
|
|
2014
Q3 | $1.1M | Sell |
7,860
-200
| -2% | -$26.1K | 0.26% | 77 |
|
|
2014
Q2 | $954K | Sell |
8,060
-1,103
| -12% | -$128K | 0.21% | 84 |
|
|
2014
Q1 | $1.13M | Sell |
9,163
-3,513
| -28% | -$426K | 0.26% | 74 |
|
|
2013
Q4 | $1.45M | Sell |
12,676
-81
| -0.6% | -$9.21K | 0.31% | 63 |
|
|
2013
Q3 | $1.43M | Sell |
12,757
-155
| -1% | -$16.8K | 0.34% | 61 |
|
|
2013
Q2 | $1.27M | Buy |
+12,912
| New | +$1.34M | 0.32% | 64 |
|
Other funds holding AMGN
FFM
L. Roy Papp & Associates's AMGN Position: Q2 2026 in Review
L. Roy Papp & Associates reduced its Amgen (AMGN) stake by 0.14% in Q2 2026, selling an estimated $3.08K and leaving 6,448 shares worth $2.33M. The position accounts for 0.25% of the portfolio, ranked #63.
L. Roy Papp & Associates first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.1M in Q3 2020. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- L. Roy Papp & Associates held 6,448 shares of Amgen worth $2.33M as of Q2 2026.
- L. Roy Papp & Associates sold 9 Amgen shares in Q2 2026, an estimated $3.08K.
- Amgen made up 0.25% of L. Roy Papp & Associates's portfolio in Q2 2026, its #63 holding.
- L. Roy Papp & Associates first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
- L. Roy Papp & Associates's Amgen position peaked at $3.1M in Q3 2020.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on L. Roy Papp & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.